3 Brilliant Growth Stocks to Buy Now and Hold for the Long Term [Yahoo! Finance]
CRISPR Therapeutics AG - Common Shares (CRSP)
Last crispr therapeutics ag - common shares earnings: 8/7 05:01 pm
Check Earnings Report
US:NASDAQ Investor Relations:
nasdaq.com/symbol/crsp/real-time
Company Research
Source: Yahoo! Finance
Artificial intelligence (AI) data center interconnectivity powerhouse Broadcom hasn't had much competition … until now. China's AI industry is mostly developing in its own silo. One company is positioned to dominate it. 10 stocks we like better than CRISPR Therapeutics › All investors would love to get rich overnight. As anyone who's been in the market for a while can attest, however, that's just not how things work. Growing wealth takes time. And, the more time you're willing and able to give your picks, the better your returns tend to be. With that as the backdrop, here's a closer look at three stocks that are not only solid long-term prospects. Granted, they will require lengthy holding periods to reach their full potential and pay off in full. This, of course, means taking the risk of stepping into a name with a future that's still a bit fuzzy and far from guaranteed. If things pan out the way they appear to, though, this risk will be well worth it. The premise of repai
Show less
Read more
Impact Snapshot
Event Time:
CRSP
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
CRSP alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
CRSP alerts
High impacting CRISPR Therapeutics AG - Common Shares news events
Weekly update
A roundup of the hottest topics
CRSP
News
- CRISPR Therapeutics (NASDAQ:CRSP) had its "buy" rating reaffirmed by analysts at Needham & Company LLC. They now have a $80.00 price target on the stock.MarketBeat
- CRISPR Therapeutics (NASDAQ:CRSP) had its "market outperform" rating reaffirmed by analysts at Citizens Jmp. They now have a $86.00 price target on the stock.MarketBeat
- CRISPR Therapeutics Provides Broad Update on Zugocaptagene Geleucel (Zugo-cel; formerly CTX112™) in Autoimmune Diseases and Hematologic MalignanciesGlobeNewswire
- Is Trending Stock CRISPR Therapeutics AG (CRSP) a Buy Now? [Yahoo! Finance]Yahoo! Finance
- Is CRISPR Therapeutics a Buy, Sell, or Hold in 2026? [Yahoo! Finance]Yahoo! Finance
CRSP
Earnings
- 11/10/25 - Beat
CRSP
Sec Filings
- 12/22/25 - Form 4
- 12/22/25 - Form 144
- 11/14/25 - Form SCHEDULE
- CRSP's page on the SEC website